The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Macrophage polarity in cancer: A review
Abstract
Macrophages are the most abundant cells within the tumor stroma displaying noticeable plasticity, which allows them to perform several functions within the tumor microenvironment. Tumor‐associated macrophages commonly refer to an alternative M2 phenotype, exhibiting anti‐inflammatory and pro‐tumoral effects. M2 cells are highly versatile and multi‐tasking cells that directly influence multiple steps in tumor development, including cancer cell survival, proliferation, stemness, and invasiveness along with angiogenesis and immunosuppression. M2 cells perform these functions through critical interactions with cells related to tumor progression, including Th2 cells, cancer‐associated fibroblasts, cancer cells, regulatory T cells (Tregs), and myeloid‐derived suppressor cells. M2 cells also have negative cross‐talks with tumor suppressor cells, including cytotoxic T cells and natural killer cells. Programed death‐1 (PD‐1) is one of the key receptors expressed in M2 cells that, upon interaction with its ligand PD‐L1, plays cardinal roles for induction of immune evasion in cancer cells. In addition, M2 cells can neutralize the effects of the pro‐inflammatory and anti‐tumor M1 phenotype. Classically activated M1 cells express high levels of major histocompatibility complex molecules, and the cells are strong killers of cancer cells. Therefore, orchestrating M2 reprogramming toward an M1 phenotype would offer a promising approach for reversing the fate of tumor and promoting cancer regression. Macrophage switching toward an anti‐inflammatory M1 phenotype could be used as an adjuvant with other approaches, including radiotherapy and immune checkpoint blockades, such as anti‐PD‐L1/PD‐1 strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
Wang, X., Luo, G., Zhang, K., Cao, J., Huang, C., Jiang, T., Liu, B., Su, L., & Qiu, Z. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3841 · Cited by 767
A peek into cancer-associated fibroblasts: origins, functions and translational impact
LeBleu, V. S., & Kalluri, R. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.029447 · Cited by 537
Chen, D., Xie, J., Fiskesund, R., Dong, W., Liang, X., Lv, J., Jin, X., Liu, J., Mo, S., Zhang, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03225-9 · Cited by 489
Albini, A., Bruno, A., Noonan, D. M., & Mortara, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00527 · Cited by 392
Kato, T., Noma, K., Ohara, T., Kashima, H., Katsura, Y., Sato, H., Komoto, S., Katsube, R., Ninomiya, T., Tazawa, H., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0205 · Cited by 367
Macrophages: The Road Less Traveled, Changing Anticancer Therapy
Guerriero, J. L. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.03.006 · Cited by 293
Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell–Mediated Tumor Immunity
Büll, C., Boltje, T. J., Balneger, N., Weischer, S. M., Wassink, M., van Gemst, J. J., Bloemendal, V. R., Boon, L., van der Vlag, J., Heise, T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3376 · Cited by 268
Parayath, N. N., Parikh, A., & Amiji, M. M. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00689 · Cited by 262
Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155
Cai, X., Yin, Y., Li, N., Zhu, D., Zhang, J., Zhang, C.-Y., & Zen, K. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs044 · Cited by 260
Zhao, P., Wang, Y., Kang, X., Wu, A., Yin, W., Tang, Y., Wang, J., Zhang, M., Duan, Y., & Huang, Y. (2018) · Chemical Science · doi:10.1039/c7sc04853j · Cited by 248
Xiang, W., Shi, R., Kang, X., Zhang, X., Chen, P., Zhang, L., Hou, A., Wang, R., Zhao, Y., Zhao, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04999-8 · Cited by 243
Molecular Mechanisms of Nitric Oxide in Cancer Progression, Signal Transduction, and Metabolism
Somasundaram, V., Basudhar, D., Bharadwaj, G., No, J. H., Ridnour, L. A., Cheng, R. Y. S., Fujita, M., Thomas, D. D., Anderson, S. K., McVicar, D. W., et al. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2018.7527 · Cited by 213
LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody–Drug Conjugates
Purcell, J. W., Tanlimco, S. G., Hickson, J., Fox, M., Sho, M., Durkin, L., Uziel, T., Powers, R., Foster, K., McGonigal, T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0327 · Cited by 205
Ou, W., Thapa, R. K., Jiang, L., Soe, Z. C., Gautam, M., Chang, J.-H., Jeong, J.-H., Ku, S. K., Choi, H.-G., Yong, C. S., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.018 · Cited by 200
Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response
Ubil, E., Caskey, L., Holtzhausen, A., Hunter, D., Story, C., & Earp, H. S. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97354 · Cited by 195
Caspase-1 cleaves PPARγ for potentiating the pro-tumor action of TAMs
Niu, Z., Shi, Q., Zhang, W., Shu, Y., Yang, N., Chen, B., Wang, Q., Zhao, X., Chen, J., Cheng, N., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00523-6 · Cited by 188
A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy
Shibata, M., Ham, K., & Hoque, M. O. (2018) · International Journal of Cancer · doi:10.1002/ijc.31561 · Cited by 187
Inhibition of Rspo-Lgr4 Facilitates Checkpoint Blockade Therapy by Switching Macrophage Polarization
Tan, B., Shi, X., Zhang, J., Qin, J., Zhang, N., Ren, H., Qian, M., Siwko, S., Carmon, K., Liu, Q., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0152 · Cited by 165
Tan, Y. S., Sansanaphongpricha, K., Xie, Y., Donnelly, C. R., Luo, X., Heath, B. R., Zhao, X., Bellile, E. L., Hu, H., Chen, H., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2807 · Cited by 155
The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance
Biancur, D. E., & Kimmelman, A. C. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.011 · Cited by 153
miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy
Huang, Q., Xia, J., Wang, L., Wang, X., Ma, X., Deng, Q., Lu, Y., Kumar, M., Zhou, Z., Li, L., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0600-x · Cited by 137
Intermittent hypoxia induces a metastatic phenotype in breast cancer
Chen, A., Sceneay, J., Gödde, N., Kinwel, T., Ham, S., Thompson, E. W., Humbert, P. O., & Möller, A. (2018) · Oncogene · doi:10.1038/s41388-018-0259-3 · Cited by 133
IL-6 influences the polarization of macrophages and the formation and growth of colorectal tumor
Chen, L., Wang, S., Wang, Y., Zhang, W., Ma, K., Hu, C., Zhu, H., Liang, S., Liu, M., & Xu, N. (2018) · Oncotarget · doi:10.18632/oncotarget.24734 · Cited by 118
Porrello, A., Leslie, P. L., Harrison, E. B., Gorentla, B. K., Kattula, S., Ghosh, S. K., Azam, S. H., Holtzhausen, A., Chao, Y. L., Hayward, M. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04355-w · Cited by 111
The Potential Biomarkers and Immunological Effects of Tumor-Derived Exosomes in Lung Cancer
Alipoor, S. D., Mortaz, E., Varahram, M., Movassaghi, M., Kraneveld, A. D., Garssen, J., & Adcock, I. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00819 · Cited by 103
Zhang, Y., Wu, L., Li, Z., Zhang, W., Luo, F., Chu, Y., & Chen, G. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b00305 · Cited by 98
Li, T., Li, K., Wang, C., Liu, X. Z., Wen, Y., Xu, Y., Zhang, Q., Zhao, Q.-Y., Shao, M., Li, Y.-Z., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.024 · Cited by 98
Wang, J., Sun, X., Ma, Q., Fu, G., Cong, L., Zhang, H., Fan, D., Feng, J., Lu, S., Liu, J., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13655 · Cited by 92
Marra, M., Salzano, G., Leonetti, C., et al. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.06.018 · Cited by 91
Functions of miR-146a and miR-222 in Tumor-associated Macrophages in Breast Cancer
Li, Y., Zhao, L., Shi, B., Ma, S., Xu, Z., Ge, Y., Liu, Y., Zheng, D., & Shi, J. (2015) · Scientific Reports · doi:10.1038/srep18648 · Cited by 90
Yi, C., Zhang, Y., Yu, Z., Xiao, Y., Wang, J., Qiu, H., Yu, W., Tang, R., Yuan, Y., Guo, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099943 · Cited by 79
Proton irradiation orchestrates macrophage reprogramming through NFκB signaling
Genard, G., Wéra, A.-C., Huart, C., Calvé, B. L., Penninckx, S., Fattaccioli, A., Tabarrant, T., Demazy, C., Ninane, N., Heuskin, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0757-9 · Cited by 79
Molecular Regulation of Bone Metastasis Pathogenesis
Wu, M., Li, C., Yiang, G., Cheng, Y., Tsai, A. P., Hou, Y.-T., Ho, Y.-C., Hou, M., & Chu, P. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489184 · Cited by 77
Andersen, R. S., Borch, T. H., Draghi, A., Gokuldass, A., Rana, M. A. H., Pedersen, M., Nielsen, M., Kongsted, P., Kjeldsen, J. W., Westergaard, M. C. W., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy139 · Cited by 76
Human hepatocellular carcinoma: Protection by melatonin
Mortezaee, K. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26586 · Cited by 72
Self-citationComplex role of NK cells in regulation of oncolytic virus–bortezomib therapy
Kim, Y., Yoo, J. Y., Lee, T. J., Liu, J. N., Yu, J., Caligiuri, M. A., Kaur, B., & Friedman, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1715295115 · Cited by 70
Ju, H., Li, H., Tian, T., Lu, Y., Bai, L., Chen, L.-Z., Sheng, H., Mo, H., Zeng, J., Deng, W., et al. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12285 · Cited by 65
Rodríguez‐García, A., Mayo, J. C., Hevia, D., Quirós-González, I., Navarro, M., & Sainz, R. M. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01017.x · Cited by 61
Donzelli, S., Milano, E., Pruszko, M., Sacconi, A., Masciarelli, S., Iosue, I., Melucci, E., Gallo, E., Terrenato, I., Mottolese, M., et al. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0990-2 · Cited by 52
STAT3 as a potential immunotherapy biomarker in oncogene-addicted non-small cell lung cancer
Attili, I., Karachaliou, N., Bonanno, L., Berenguer, J., Bracht, J. W. P., Codony‐Servat, J., Codony, C., Ito, M., & Rosell, R. (2018) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835918763744 · Cited by 45
Borghese, C., Casagrande, N., Pivetta, E., Colombatti, A., Boccellino, M., Amler, E., Normanno, N., Caraglia, M., Rosa, G. D., & Aldinucci, D. (2017) · Oncotarget · doi:10.18632/oncotarget.17216 · Cited by 27
Control of polarization and tumoricidal activity of macrophages by multicellular spheroid formation
Tanaka, Y., Nishikawa, M., Mizukami, Y., Kusamori, K., Ogino, Y., Nishimura, S., Shimizu, K., Konishi, S., Takahashi, Y., & Takakura, Y. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.006 · Cited by 23
Cited by
Orecchioni, M., Ghosheh, Y., Pramod, A. B., & Ley, K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01084 · Cited by 2,063
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Xia, Y., Rao, L., Yao, H., Wang, Z., Ning, P., & Chen, X. (2020) · Advanced Materials · doi:10.1002/adma.202002054 · Cited by 949
The Next Decade of Immune Checkpoint Therapy
Sharma, P., Siddiqui, B. A., Anandhan, S., Yadav, S. S., Subudhi, S. K., Gao, J., Goswami, S., & Allison, J. P. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1680 · Cited by 750
Cancer stem cells (CSCs) in cancer progression and therapy
Najafi, M., Farhood, B., & Mortezaee, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27740 · Cited by 573
Self-citationImmunotherapy: Reshape the Tumor Immune Microenvironment
LV, B., Wang, Y., Ma, D., Cheng, W., Liu, J., Yong, T., Chen, H., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844142 · Cited by 482
Metadata
- Authors
- Najafi, M., Hashemi Goradel, N., Farhood, B., Salehi, E., Nashtaei, M. S., Khanlarkhani, N., Khezri, Z., Majidpoor, J., Abouzaripour, M., Habibi, M., Kashani, I. R., & Mortezaee, K.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2018-09-30
- Volume
- 120
- Issue
- 3
- Pages
- 2756-2765
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2895594057
- Cited by
- 489
- References
- 43
- FWCI
- 14.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.